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Abstract: A spectrophotometric method has been proposed for the 
determination of four phenolic drugs; salbutamol, ritodrine, amoxicillin and 
isoxsuprine. The method is based on the oxidation of 2, 4- dinitrophenyl-
hydrazine and coupling of the oxidized product with drugs to give intensely 
colored chromogen. Under the proposed optimum condition, beer’s law was 
obeyed in the concentration range of 2.5-17, 2-29, 4-33 and 5-30 µg/mL for 
salbutamol, ritodrine, amoxicillin and isoxsuprine respectively. The limit of 
detection (LOD) and limit of quantification (LOQ) were 0.2, 0.83, 0.09, 
0.84 µg/mL and 0.66, 2.79, 0.3 and 2.81 µg/mL in the same order. No 
interference was observed from common pharmaceutical adjuvants. The 
ringbom plots and low relative standard deviation assert the applicability of 
this method. The suggested method was further applied for the determinations 
of drugs in commercial pharmaceutical dosage forms, which was compared 
statistically with reference methods by means of t- test and F- test and were 
found not to differ significantly at 95% confidence level. The procedure is 
characterized by its simplicity with accuracy and precision. 
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Introduction 
Salbutamol sulfate (SLB), ritodrine HCl (RTD), amoxicillin trihydrate (AMOX) and 
isoxsuprine HCl (IXP) are frequently prescribed biologically active compounds. Salbutamol 
sulfate and ritodrine is beta-2 agonist agent. SLB is used as a bronchodilator in the 
management of reversible airway obstruction. RTD is a uterine relaxant drug used to arrest 
premature labour. Amoxicillin trihydrate (AMX) is a broad spectrum antibiotic  agent acting  
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on both gram positive and gram negative bacteria. Isoxsuprin, a derivative of adrenaline, is 
an alpha receptor antagonist and beta receptor agonist, which is used as vasodilator and 
uterine relaxant.  
 Among the various methods available for the estimation of these drugs such as HPLC, 
Electrophoresis, Gas chromatography, Spectrophotometry method is still a preferred 
technique due to its simplicity and economy. Several colorimetric methods are available for 
the estimation of salbutamol1-6, ritodrine6-12, amoxicillin13-16 and isoxsuprine6, 17-18. 
 The present work is an attempt to develop a rapid and sensitive method for the colorimetric 
estimation by 2, 4 dinitrophenylhydrazine (2, 4 DNP). 2, 4 DNP, also known as Brady’s 
reagent, has been used for the characterization of aldehyde and ketones by hydrazone formation. 
We report here its application in the estimation of phenolic drugs. The method is based on the 
oxidation of 2, 4 DNP to produce diazonium cation, which couples with phenolic drugs to yield 
highly absorbing chromagen. Studies on different variables affecting the reaction were 
optimized. The developed method is simple, accurate and applicable for their determination in 
pharmaceutical formulations. All the above mentioned drugs are official in BP 2005. 
Experimental  
A JASCO (Model UVIDEC-610 UV-VIS spectrophotometry with 1cm matched quartz 
cuvettes was used for all absorbance measurements. 
Reagents and solutions 
Analytical reagent grade chemicals and double distilled water were used throughout the 
experiment. Salbutamol sulfate (Cipla, India), ritodrine HCl (Duphar-Interfran Ltd, India), 
amoxicillin trihydrate (Sigma Aldrich, USA) and isoxsuprine HCl (Sigma Aldrich, USA) 
were procured and used as received. Stock solutions of each drug containing 100 µg/mL 
were prepared by dissolving 10 mg of the respective drugs in 100 mL of water. The 
solutions were further diluted quantitatively according to their linearity range. The 
pharmaceutical preparations were purchased from a local market and analysed.  
Preparation of 2, 4-DNP reagents  
A 0.04% w/v and a 0.08% w/v of the reagent solution were freshly prepared by dissolving 0.04 g 
and 0.08 g of 2, 4 DNP (SRL Chemicals, India) in 1 mL  and 2 mL of concentrated H2SO4 
respectively and diluting to 100 mL with water.   
Preparation of oxidizing agents 
For amoxicillin, a 0.15% w/v potassium periodate (The British Drug House, England) and 
for  other drugs, a 4% w/v potassium iodate (Loba-Chemie, India) solution were prepared 
by dissolving suitable quantities in water. 
Preparation of tablet/capsule sample solution 
Twenty tablets of each drug was weighed, powdered and mixed thoroughly. Similarly, ten 
capsule of AMX were carefully evacuated, and mixed. A quantity equivalent to 10 mg of each 
drug was transferred to 100 mL volumetric flask. The drugs were dissolved in water, shaken 
well, sonicated and made up to the volume with water. The resultant solutions were filtered and 
analysed as described under general procedure.  
General procedure 
Accurately measured suitable volume of SLB, RTD and IXP were transferred from stock 
solution to 10 mL volumetric flasks, which could be diluted quantitatively to obtain 2.5-17,  
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2-29 and 5-30 µg/mL respectively. To each flask containing drugs in the order mentioned 
above, 1, 2  and 1.5 mL of 2, 4 DNP (0.04%) and  2, 4 and 1.5 mL of KIO3 (4%)  were 
added, which were made alkaline by adding 1 mL each of NaOH (10 N). Similarly, for 
AMOX, an accurate quantity of drugs that could be diluted to 4-33 µg/mL was transferred in 
10 mL volumetric flasks followed by  addition of 1.5 mL of 2, 4 DNP (0.08%), 1.5 mL of 
KIO4 (0.15%) and 0.5 mL of NaOH (10 N). The red color hence developed was further 
diluted to the volume with water. 
Results and Discussion 
Spectral characteristic 
The absorption spectra of the reaction product of oxidized 2, 4 DNP with drugs show 
maximum absorption (λmax) at 540, 510, 520 and 520 nm for SLB, RTD, AMOX and IXP 
respectively. The blank solution was slightly yellowish in color that had negligible 
absorbance at the λmax in which the drugs were analysed. The thus formed color was stable 
for more than two hours. A temperature range of 20-30 0C is preferred for the reaction. 
Reaction sequence and stoichiometric relationship 
The 2, 4 DNP is oxidized by KIO3 or KIO4 to give diazonium cation that reacts with drugs 
by electrophilic substitution at the phenolic ring to give deep colored chromogens. The 
proposed reaction sequence for RTD is shown in Figure 1. The reaction sequence for other 
drugs is expected to follow the same sequence. The combining ratio was evaluated by the 
Job’s method of continuous variation and molar ratio method, which shows that the complex 
formed between the drugs, SLB, RTD, IXP and AMX with 2, 4 DNP were 1:1, 1:2, 1:1 and 
1:1 respectively. The plot of Log [Absorbance] against Log [2, 4 DNP] and the drugs in 
limiting logarithmic method further confirmed the result. Figure 2 shows the continuous 
variation plot and limiting logarithmic plot for RTD. 
 
Figure 1. Proposed reaction mechanism. 
b 
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Figure 2.(a) Job’s method of continuous variation plot and (b) Limiting logarthimic plot 
for the molar reactivity for RTD. The concentration of RTD and 2, 4 DNP is 2×10-3 M. 
Optimum reaction condition 
By varying one and keeping other experimental parameters and the amount of drug constant, the 
effect of 2, 4-DNP, oxidizing agents and NaOH were studied. Maximum color intensity was 
obtained when 0.8-1.3, 1.8-2.1, 1.3-1.5 mL of 2, 4 DNP and 1.8-2.1, 3.7-4.2, 1.5-1.7 mL of iodate 
were added to SLB, RTD and IXP respectively. The amoxicillin produced more intense color when 
Potassium periodate was used as an oxidizing agent. The optimum quantity for amoxicillin was 
found to be 1.4-1.5 mL of 2, 4 DNP and 1.3-1.6 mL of potassium periodate. Different 
concentrations of sodium hydroxide was used for maximum color development and was found that 
1 mL of 10 N NaOH was optimum except for AMX in which 0.5 mL of 10N NaOH was needed. 
During the analysis, the quantities of the reagents as mentioned in general procedure were taken.  
Validation of the proposed method 
Linearity, detection and quantification limit 
Calibration graphs were constructed using standard solutions under optimum experimental 
condition. A linear relationship was observed between the absorbance and concentration of 
drugs from 2.5-17, 2-29, 4-33 and 5-30 µg/mL for SLB, RTD, AMOX, and IXP respectively. 
The molar absorptivity and sandell’s sensitivity for each drug were calculated from beer’s law. 
The Ringbom plots demonstrated the range of 3-16, 5-26, 5-31 and 7-25 µg/mL for SLB, RTD, 
AMOX and IXP respectively. The graph showed a negligible intercept, which was calculated 
by the least-square method’s regression equation:  
A = a + bc 
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 where, A is the absorbance of solution in a 1 cm cell, a is the intercept, b is the slope, and 
c is the concentration of the measured solution in µg/mL. The high molar absorptivities of the 
resulting colored solution indicated high sensitivity of the method. The limit of detection 
(LOD) and the limit of quantification (LOQ) value were determined using the formula  
LOD or LOQ = К SD/b 
 where, К = 3 for LOD and 10 for LOQ, SD and b stand for standard deviation of the 
blank and slope, respectively. Repeatability and level of precision was tested by analyzing 
six replicate samples containing 13, 15, 20 and 16 µg/mL and was found to be adequate for 
quantification of drugs as shown by their relative standard deviation. The confidence limits 
for the slope of line of regression and the intercept were computed using the relation, b±tSb 
and a±tSa at 95% confidence level. The results are shown in Table 1. The error (Sc) in the 
determination of a given concentration of drugs was defined by the expression where, 
Sc = b
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  y and x are the average values of the absorbance and concentration, respectively, for n 
standard samples. It is clear from the graph that the error is reached minimum when 
absorbance corresponding to about 10, 15, 13 and 15 µg/mL of SLB, RTD, AMOX and IXP 
respectively, when the actual absorbance is equal to the average absorbance. The plot of 
error, Sc vs. concentration of RTD is shown in Figure 3. 
Table 1. Optical characteristics and statistical data of the regression equation for the reaction 
of the proposed method. 
Parameters Optical Characteristic 
 SLB    RTD AMOX IXP  
Colour Reddish Reddish Reddish Reddish 
λmax, nm 540 510 520 520 
Beer’s Law range, µg/mL 2.5-17 2-29 4-33 5-30 
Molar absorptivity, L/mol/cm ×104 2.19 0.741 1.0 8.04 
Sandell’s sensitivity, µg/cm2  0.0263 0.0436 0.0418 0.0419 
Limit of Detection, µg/mL 0.2 0.837 0.09 0.8451 
Limit of quantification, µg/mL 0.66 2.79 0.3 2.817 
Ringbom plot range, µg/mL 3-16 5-26 5-31 7-25 
Regression Equation (Y)a     
Slope (b) 0.036 0.0252 0.0221 0.0275 
Standard deviation of Slope(Sb) ×10-4 4.8 8.35 2.66 4.198 
Intercept (a) 0.0129- 0.0125 0.0151 0.0424 
Standard deviation of Intercept (Sa)×10-3  5.84 14 5.0 7.88 
Correlation Coefficient(r) 0.9995 0.9993 0.9987 0.9993 
Relative standard deviationb 0.185 0.349 0.223 0.236 
±tsb ×10-3 1.33 2.31 7.36 1.165 
±tsa
 
 0.0152 0.0387 0.0138 0.02187 
aA = a + bc, where c is the concentration of the measured solution in µg/mL. ±tsb= Confidence 
interval for Slope at 95% Confidence Level, ±tsa= Confidence interval for Intercept at 95% 
Confidence Level b Average of six determination (concentration of 13, 15, 20 and 16 µg/mL of pure 
drugs of SLB, RTD, AMX, and IXP respectively).  
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Figure 3. Plot of error in the determination of RTD 
Interference studies  
The effect of common excipients used in the pharmaceutical preparation were studied by 
analyzing synthetic sample solutions containing the quantity of drugs as mentioned in 
Table 2 in presence of 100 fold more concentration of each excipients. The tolerance limit 
was defined as the concentration which gave an error of ±3.0% in the determination of 
drugs. The common excipients such as sodium chloride, starch, dextrose, lactose, talc, 
carboxymethyl cellulose, magnesium stearate, sucrose, had no effect in the analysis.  
Table 2. Recovery of drugs from solution in presence of a 100 fold concentration of various 
additives used as excipients in formulation. 
Excipients Recovery±R.S.Da 
 SLBb    RTDc AMOXd IXPe 
Dextrose 99.9±0.7 99.9±0.5 99.8±0.5 99.8±0.4 
Lactose  100±0.2 99.9±0.2 99.9±0.4 99.8±0.1 
Sucrose 99.9±0.5 99.9±0.1 99.8±0.2 99.9±0.4 
Starch 99.9±0.1 99.8±0.4 99.9±0.1 99.9±0.3 
Talc 99.8±0.4 99.9±0.3 99.9±0.4 99.7±0.0 
Carboxymethyl  cellulose 99.8±0.4 99.8±0.5 99.8±0.5 99.8±0.3 
Magnesium Sterate 99.8±0.5 99.7±0.7 99.8±0.5 99.7±0.5 
Sodium Chloride 100±0.1 100±0.1 100±0.2 100±0.2 
aMean of 3 determination, b Concentration of SLB used – 10 µg/mL, c Concentration of RTD used– 15 µg /mL, 
d
 Concentration of AMOX used– 15 µg /mL, e Concentration of IXP used– 15 µg /mL 
Precision studies 
The short term precision (intraday precision) of the drugs were evaluated by measuring 5 
independent samples at 3 different concentration levels (4.0, 8.0, 12.0 µg/mL for SBM, 10.0, 
15.0, 20.0 µg/mL for RTD, 15.0, 20.0, 25.0 µg/mL for AMOX, and 15.0, 20.0, 25.0 µg/mL for 
IXP). Similarly, the assay for daily precision (interday precision) at the same concentration 
level was repeated for 5 consecutive days (Table 3). The available pharmaceutical dosage 
forms of the investigated drugs were analysed by the proposed method. The precision of the 
method was checked by taking six replicate measurements. The results obtained by the 
proposed and the reference methods for the dosage forms were compared statistically by 
means of F- and t- test and were found not to differ significantly at 95% confidence level. The 
reliability and accuracy of the proposed method were further ascertained through recovery 
studies using the standard addition method by adding different amount of standard drugs to the 
preanalyzed dosage forms such that the cumulative amount after adding the drugs did not 
exceed their linearity range (Table 4). 
Concentration of RTD, µg/mL 
Er
ro
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Table 3. Intraday and interday precision data. 
Formulation Amount taken, 
µg/mL 
Intraday,  
%Recovery ±R.S.Da 
Interday,  
%Recovery ±R.S.Db 
SBM 4.0 3.99±0.1 3.98±0.1 
 8.0 8.01±0.3 7.98±0.3 
 12.0 12.0±0.2 12.07±0.5 
RTD 10 9.99±0.5 9.97±0.7 
 15 14.97±0.6 15.01±0.9 
 20 20.07± 1.2 20.10±0.9 
AMOX 15 15.0±0.7 14.99±0.9 
 20 19.98±0.3 20.0±0.9 
 25 25.0±0.5 25.03±0.5 
IXP 15 15.0±0.4 15.05±0.7 
 20 20.01±1.2 20.09±1.2 
 25 25.02±0.8 25.07±1.3 
a
 Mean of 5 determinations, b Mean of 5 determinations performed over a period of 5 days 
Table 4. Analysis of drugs in pharmaceutical formulations. 
Formulation Labelled, 
mga 
Amount found by 
proposed method±S.D, 
mga 
Reference 
method±S.D a* 
% Recovery by 
proposed methodsb 
Asthalinc 4 3.96±0.032 
F = 1.64 
T = 0.94 
3.98±0.041 (6) 99.0±0.3 
Yutopard 10 9.97±0.12 
F = 1.5 
T = 0.51 
10.01±0.15 (11) 99.7±0.33 
Mox 250e 250 250.0±0.14 
F = 1.36 
T = 0.66 
249.87±0.12 (14) 100.00±0.02 
Duvadilanf 10 10.00±0.25 
F = 1.34 
T = 1.2 
9.81±0.29 (6) 99.9±0.36 
a
 Average ± standard deviation of six determination; the t- and F- values obtained after comparison to the 
reference methods have following theoretical values at 95% confidence limit; t=  2.44  F= 5.05, bAfter 
adding four different amounts of pure drugs to the fixed concentration of preanalysed  pharmaceutical 
formulations, cSBM equivalent to 4 mg/tablet (Cipla, India), dRTD equivalent to 10 mg/tablet (Alimbic, 
India), eAMX equivalent to 250 mg/Capsule (Ranbaxy, India), fIXP equivalent to 10 mg/tablet Tablet 
(Duphas Interfran, India)*References inside the bracket indicated reported methods given under references. 
Conclusion 
We have proposed a new spectrophotometric method for the determination of phenolic drugs, 
which is fairly sensitive, simple, and economical with reasonable precision and accuracy. 
The optical parameters and statistical comparison justify this method for application in 
routine drug estimation in pure and dosage forms. Also, the procedures do not involve any 
critical reaction conditions or tedious sample preparation steps. So, the recommended 
method is well suited for the assay and evaluation of drugs in pharmaceutical preparation 
and can also be considered as a general method for the quantification of phenolic drugs. 
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